Chu De Quebec-universite Laval
Clinical trials sponsored by Chu De Quebec-universite Laval, explained in plain language.
-
Can extra antibodies shield myeloma patients from infections during powerful new treatment?
Disease control Recruiting nowThis study looks at multiple myeloma patients who are receiving a type of immunotherapy called a BCMA-directed T cell engager. These treatments can weaken the immune system and raise the risk of serious infections. The trial will compare two levels of immunoglobulin (antibody) su…
Phase: PHASE4 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New study aims to find gentler radiation for prostate cancer
Disease control Recruiting nowThis study compares two radiation therapy schedules for men with localized prostate cancer. One uses fewer, stronger doses (ultra-hypofractionated) and the other uses slightly more, moderate doses. Both are combined with a brachytherapy boost. The goal is to see which approach ca…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
Prostate cancer patients: which radiation is easier on you?
Disease control Recruiting nowThis study compares two types of radiation therapy for men with low- or intermediate-risk prostate cancer: SBRT (a precise, high-dose external beam treatment) and LDR brachytherapy (implanting tiny radioactive seeds). The goal is to see which causes fewer urinary and bowel side e…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
Could a prostate drug help beat bladder cancer? new trial aims to find out
Disease control Recruiting nowThis study tests whether adding the drug bicalutamide to standard BCG therapy can lower the chance of bladder cancer returning. About 160 men with non-muscle invasive bladder cancer will be randomly assigned to receive either BCG alone or BCG plus bicalutamide. The goal is to see…
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Lab-Grown skin patch could mend wounds for rare blistering disease patients
Disease control Recruiting nowThis early-stage trial tests a new skin graft made from a patient's own cells, genetically modified to produce a missing protein that helps skin stay attached. The graft is designed to be permanent and aims to heal wounds in people with recessive dystrophic epidermolysis bullosa …
Phase: PHASE1, PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New study tests nerve block to stop chronic pain after mastectomy
Symptom relief Recruiting nowThis study compares a nerve block (paravertebral block) to standard pain medication in 60 women having a mastectomy with immediate breast reconstruction. The goal is to see if the nerve block reduces pain right after surgery and may help prevent long-term chronic pain. Participan…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Symptom relief
Last updated May 26, 2026 03:14 UTC
-
New therapy aims to ease cancer fear in high-risk women
Symptom relief Recruiting nowThis study tests if a special online group therapy program can help women with BRCA1/2 gene mutations who have had breast or ovarian cancer feel less afraid of the cancer returning. About 250 women will take part in 11 weekly online sessions. Researchers will compare those who st…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Symptom relief
Last updated May 26, 2026 03:04 UTC
-
Could a simple questionnaire unlock hidden bone disease clues?
Knowledge-focused Recruiting nowThis study aims to see if a self-administered questionnaire can accurately capture family history of rare genetic bone diseases in adults with osteoporosis. Researchers will compare the questionnaire answers to detailed family trees (pedigrees) from 58 participants. The goal is t…
Sponsor: CHU de Quebec-Universite Laval • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
Nailfold camera test may speed up connective tissue disease diagnosis
Knowledge-focused Recruiting nowThis study looks at whether a quick, painless test called capillaroscopy (examining tiny blood vessels at the base of the fingernail) can help doctors diagnose specific connective tissue diseases sooner in people with undifferentiated connective tissue disease (UCTD). About 40 ad…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC